Michel Bublot,Frederic REYNARD,François-Xavier LE GROS
申请号：
US15434353
公开号：
US20170224807A1
申请日:
2017.02.16
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The present invention encompasses engineered Newcastle Disease Virus (NDV) vaccines or compositions. The vaccine or composition may be a recombinant vaccine. The invention also encompasses recombinant vectors encoding and expressing avian pathogen antigens, more specifically avian influenza proteins, epitopes or immunogens. Such vaccines or compositions can be used to protect animals, in particular avian, against disease.
